Showing results (11-20 of 9,894) with videos related to

Sort By:
Pageof 990
Bone Marrow Transplantation|September 26, 2001
Late onset post-transplantation lymphoproliferative disease of recipient origin following cytogenetic relapse and occult autologous haematopoietic regeneration after allogeneic bone marrow transplantation for acute myeloid leukaemiaW Y Au, A K Lie, C K Lee, et al.
Bone Marrow Transplantation|September 26, 2001
Immune recovery and immunotherapy after stem cell transplantation in childrenJ M Vossen, R Handgretinger
Bone Marrow Transplantation|September 26, 2001
Infections after stem cell transplantation in children: state of the art and recommendationsG Dini, E Castagnola, P Comoli, et al.
Bone Marrow Transplantation|October 11, 2001
High-dose carboplatin with etoposide in patients with recurrent thymoma: the Indiana University experienceN Hanna, V S Gharpure, R Abonour, et al.
Bone Marrow Transplantation|October 11, 2001
Autologous stem cell transplantation for non-Hodgkin's lymphoma: comparison of radiation-based and chemotherapy-only preparative regimensF Gutierrez-Delgado, D G Maloney, O W Press, et al.
Bone Marrow Transplantation|April 3, 2001
Urinary trypsin inhibitor concentration can predict the immunological insult of chemotherapy and complications after bone marrow transplantationS Yamada, H Takatsuka, Y Takemoto, et al.
Bone Marrow Transplantation|April 3, 2001
Aerobic bacterial and fungal infections in peripheral blood stem cell transplantsG Aksu, M Z Ruhi, H Akan, et al.
Bone Marrow Transplantation|March 30, 2001
Severe cardiac toxicity in hematological stem cell transplantation: predictive value of reduced left ventricular ejection fractionK Fujimaki, A Maruta, M Yoshida, et al.
Bone Marrow Transplantation|March 30, 2001
Treatment of post-transplant lymphoproliferative disease with induction chemotherapy followed by haploidentical peripheral blood stem cell transplantation and RituximabS Skoda-Smith, V K Douglas, P Mehta, et al.
Bone Marrow Transplantation|March 30, 2001
Preoperative high-dose chemotherapy with peripheral blood stem cell support as a primary management of locally advanced breast cancerX Wang, J Tang, J Wu, et al.
Pageof 990